NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) and Royalty Pharma (NASDAQ:RPRX – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Insider & Institutional Ownership 23.3% of NovaBay Pharmaceuticals […]
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 30,500 shares, a decline of 77.7% from the April 30th total of 137,000 shares. Based on an average daily trading volume, of 8,110,000 […]
StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research note published on Saturday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % Shares of NYSE:NBY opened at $0.13 on Friday. NovaBay Pharmaceuticals has a 12 month low of $0.07 and a 12 […]
StockNews.com initiated coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Price Performance Shares of NYSE NBY opened at $0.13 on Friday. The company has a 50 day simple moving average of $0.10 […]
Analysts at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. NovaBay Pharmaceuticals Stock Down 5.9 % NYSE:NBY opened at $0.13 on Friday. The business’s 50-day simple moving average is $0.10 […]